Greg Kidd to Gain Majority Stake in Know Labs and Implement Bitcoin Treasury Plan

Know Labs, Inc. (NYSE American: KNW), a technology company specializing in innovative non-invasive health monitoring solutions, has recently announced an agreement with Goldeneye 1995 LLC, an affiliate of Greg Kidd, a prominent fintech investor and former Ripple Chief Risk Officer. This agreement will result in the acquisition of a controlling interest in Know Labs by Goldeneye 1995 LLC, with Mr. Kidd assuming the role of Chief Executive Officer and Chairman of the Board of Directors.

The terms of the agreement outline that the Buyer will acquire a specified number of shares of Know Labs’ common stock by exchanging 1,000 Bitcoin and a cash sum, which will be used to address existing debt, retire outstanding preferred equity, and provide additional working capital. The utilization of Bitcoin as part of the Company’s treasury strategy aims to provide investors with exposure to the digital asset, offering opportunities for sustainable growth and long-term shareholder value.

Greg Kidd expressed his enthusiasm for implementing a Bitcoin treasury strategy within Know Labs, highlighting the favorable market and regulatory conditions for such an approach. With a focus on digital assets, Mr. Kidd and his team plan to transition their existing Bitcoin yield generation strategy to the public markets, leveraging their expertise in this domain.

Upon completion of the transaction, the Company’s balance sheet will primarily consist of Bitcoin holdings. This shift will be evaluated using the net asset value (mNAV) metric to gauge the premium or discount attributed to the Company’s market valuation relative to its Bitcoin assets. With an anticipated market capitalization of $128 million, Know Labs’ Bitcoin holdings are expected to represent a significant portion of their market capitalization at closing, showcasing a strategic alignment with the potential of this digital asset.

Founder Ron Erickson will continue to play a key role within Know Labs, leading a new division focused on advancing the Company’s research efforts in non-invasive medical technology. Mr. Erickson expressed his optimism regarding the partnership with Greg Kidd, emphasizing the innovative direction this collaboration will steer Know Labs towards, ensuring a robust future for the organization.

The Know Labs Board of Directors has unanimously approved the transaction, which is slated to conclude in the third quarter of 2025, pending shareholder approval and fulfillment of customary closing conditions. Cohen & Company Capital Markets and Lowenstein Sandler LLP are serving as financial and legal advisors to the Buyer, respectively, while Sichenzia Ross Ference Carmel LLP is representing Know Labs in a legal capacity.

Greg Kidd’s background as the co-founder and CEO of Hard Yaka and majority shareholder of Vast Bank underscores his extensive experience in venture capital and digital assets. With notable early investments in various high-profile companies, including Twitter, Square, Coinbase, and Ripple, Mr. Kidd brings a wealth of knowledge to his role as the prospective Chief Executive Officer of Know Labs.

Know Labs is a publicly traded company on the NYSE American Exchange, known for its innovative spectroscopy technology that enables non-invasive health monitoring solutions. The Company’s platform technology allows the identification and monitoring of analytes in a user-friendly manner, positioning them as a key player in the healthcare technology space. Their upcoming product, a non-invasive glucose monitor, is a significant step in providing accessible and affordable real-time information on blood glucose levels, highlighting their commitment to advancing healthcare solutions.

In sum, the strategic partnership between Know Labs and Greg Kidd represents a significant milestone for the Company’s future trajectory, with a strong emphasis on digital assets and sustainable growth strategies. This collaboration underlines the organization’s commitment to innovation in healthcare technology and signals a promising outlook for Know Labs in the evolving landscape of digital assets and health monitoring solutions.